ArticleCancer science2022

High PD-L1 level of advanced hepatic lymphoepithelioma-like carcinoma response favorably to lenvatinib plus toripalimab.

Yueting Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.